Publicaciones en colaboración con investigadores/as de Hospital Clinic Barcelona (19)

2023

  1. External clinical validation of automated software to identify structural abnormalities and microhaemorrhages in nailfold videocapillaroscopy images

    Clinical and experimental rheumatology, Vol. 41, Núm. 8, pp. 1605-1611

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

2021

  1. Multidisciplinary care and units for uveitis in the internal medicine departments in Spain: Survey of the Systemic Autoimmune Diseases Group

    Revista Clinica Espanola, Vol. 221, Núm. 4, pp. 221-225

  2. SARS-CoV-2 infection in patients with primary Sjögren syndrome: Characterization and outcomes of 51 patients

    Rheumatology (United Kingdom), Vol. 60, Núm. 6, pp. 2946-2957

2020

  1. A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients

    Rheumatology International, Vol. 39, Núm. 11, pp. 1875-1882

2018

  1. Interstitial lung disease in systemic sclerosis: data from the spanish scleroderma study group

    Rheumatology International, Vol. 38, Núm. 3, pp. 363-374

  2. Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's Disease

    Ophthalmology, Vol. 125, Núm. 9, pp. 1444-1451

2017

  1. Clinical and epidemiological differences between men and women with systemic sclerosis: A study in a Spanish systemic sclerosis cohort and literature review

    Clinical and Experimental Rheumatology, Vol. 35, pp. S89-S97

2016

  1. Digital ulcers and cutaneous subsets of systemic sclerosis: Clinical, immunological, nailfold capillaroscopy, and survival differences in the Spanish RESCLE Registry

    Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 2, pp. 200-208

2015

  1. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis

    Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35

  2. Somatic NLRP3 mosaicism in Muckle-Wells syndrome. A genetic mechanism shared by different phenotypes of cryopyrin-associated periodic syndromes

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 3, pp. 603-610

2012

  1. Adalimumab for the treatment of behçet's disease: Experience in 19 patients

    Rheumatology (United Kingdom), Vol. 51, Núm. 10, pp. 1825-1831

  2. Influence of the IL6 gene in susceptibility to systemic sclerosis

    Journal of Rheumatology, Vol. 39, Núm. 12, pp. 2294-2302

  3. Registry of the Spanish Network for Systemic Sclerosis: Clinical Pattern According to Cutaneous Subsets and Immunological Status

    Seminars in Arthritis and Rheumatism, Vol. 41, Núm. 6, pp. 789-800

2004

  1. Intolerancia a la hidroxicloroquina comercializada en España (Dolquine®) en pacientes con patología autoinmune

    Revista Clinica Espanola, Vol. 204, Núm. 11, pp. 588-591

1999

  1. Association of antiphospholipid antibodies with retinal vascular disease in systemic lupus erythematosus

    Seminars in Arthritis and Rheumatism, Vol. 28, Núm. 5, pp. 326-332

1998

  1. Fulminant thrombotic thrombocytopenic purpura in systemic lupus erythematosus

    Scandinavian Journal of Rheumatology, Vol. 27, Núm. 1, pp. 76-77

  2. Trombosis venosa cerebral en la enfermedad de Behcet: Aparicion a pesar del tratamiento anticoagulante

    Revista Clinica Espanola